Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.91
+0.12 (2.07%)
Jun 8, 2026, 9:53 AM EDT - Market open
Strata Critical Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 58.72 | 30.97 | 16.07 | 27.87 | 41.34 | 2.6 |
Short-Term Investments | 0.07 | 30.26 | 108.76 | 138.26 | 150.74 | 279.37 |
Cash & Short-Term Investments | 58.79 | 61.23 | 124.83 | 166.14 | 192.08 | 281.97 |
Cash Growth | -51.01% | -50.95% | -24.86% | -13.51% | -31.88% | -7.29% |
Accounts Receivable | 39.6 | 39.96 | 19.82 | 21.01 | 10.88 | 5.55 |
Other Current Assets | 25.75 | 25 | 16.09 | 19.12 | 15.17 | 7.43 |
Total Current Assets | 124.15 | 126.19 | 160.74 | 206.26 | 218.13 | 294.95 |
Net Property, Plant & Equipment | 44.28 | 39.55 | 31.3 | 26.38 | 19.73 | 2.76 |
Other Intangible Assets | 46.31 | 47.5 | 7.96 | 20.52 | 46.37 | 24.42 |
Goodwill | 88.59 | 88.21 | 15.54 | 40.37 | 39.45 | 13.33 |
Long-Term Investments | - | - | - | - | - | 0.2 |
Other Long-Term Assets | 24.29 | 24.02 | 41.13 | 1.4 | 1.36 | 0.23 |
Total Assets | 327.62 | 325.47 | 256.68 | 294.94 | 325.03 | 335.88 |
Accounts Payable | 19.96 | 19.14 | 9.22 | 23.86 | 16.54 | 6.37 |
Current Portion of Leases | 0.99 | 0.65 | 0.68 | 4.79 | 3.36 | 0.44 |
Unearned Revenue | - | - | - | 6.85 | 6.71 | 5.98 |
Other Current Liabilities | - | - | 12.82 | - | - | - |
Total Current Liabilities | 20.94 | 19.79 | 22.73 | 35.49 | 26.61 | 12.78 |
Long-Term Leases | 3.48 | 2.66 | 2.34 | 19.74 | 14.97 | 0.28 |
Other Long-Term Liabilities | 17.46 | 23.95 | 9.68 | 5.41 | 8.96 | 31.45 |
Total Long-Term Liabilities | 20.95 | 26.61 | 12.01 | 25.15 | 23.93 | 31.73 |
Total Liabilities | 41.89 | 46.4 | 34.74 | 60.64 | 50.54 | 44.51 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 429.12 | 424.62 | 407.08 | 390.08 | 375.87 | 368.68 |
Accumulated Other Comprehensive Income | - | - | 1.75 | 3.96 | 2.29 | -0.9 |
Retained Earnings | -143.4 | -145.55 | -186.9 | -159.75 | -103.68 | -76.42 |
Shareholders' Equity | 285.73 | 279.07 | 221.94 | 234.3 | 274.49 | 291.37 |
Total Liabilities & Equity | 327.62 | 325.47 | 256.68 | 294.94 | 325.03 | 335.88 |
Total Debt | 4.47 | 3.31 | 3.02 | 24.53 | 18.33 | 0.72 |
Net Cash (Debt) | 54.32 | 57.92 | 121.81 | 141.61 | 173.75 | 281.25 |
Net Cash Growth | -6.22% | -52.45% | -13.98% | -18.50% | -38.22% | -7.32% |
Net Cash Per Share | 0.64 | 0.71 | 1.57 | 1.93 | 2.44 | 3.62 |
Book Value | 285.73 | 279.07 | 221.94 | 234.3 | 274.49 | 291.37 |
Book Value Per Share | 3.39 | 3.40 | 2.86 | 3.19 | 3.85 | 3.75 |
Tangible Book Value | 150.83 | 143.36 | 198.43 | 173.41 | 188.68 | 253.62 |
Tangible Book Value Per Share | 1.79 | 1.75 | 2.56 | 2.36 | 2.65 | 3.26 |